Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.37 |
| ▸ | MME | P08473 | 4/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6557573 | 0.98 | CYP2C19 (0.45) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL5813882 | 0.80 | CETP (0.42) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL1812100 | 0.80 | CYP2C19 (0.56) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL265530 | 0.78 | CYP2C19 (0.60) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL30186714 | 0.78 | CYP2C19 (0.60) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL9640977 | 0.78 | CYP2C19 (0.60) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL990466 | 0.77 | CYP2C19 (0.39) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL3968163 | 0.76 | CYP2C19 (0.42) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL5381962 | 0.75 | CYP2C19 (0.39) | CYP2C19CETPMMECYP4F2CYP4A11 | |
| SCHEMBL1055977 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2802580-B1 | SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE | BAYER IP GMBH (DE) | 2016-07-13 | — | — | EP | disclosed |
| EP-2611802-B1 | BICYCLIC AZA-HETEROCYCLES AND THEIR USE | BAYER IP GMBH (DE) | 2016-02-24 | — | — | EP | disclosed |
| EP-2802580-A1 | SUBSTITUTED TRIAZINE DERIVATIVES AND USE THEREOF AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE | Bayer Intellectual Property GmbH (DE) | 2014-11-19 | — | — | EP | disclosed |
| WO-2013104597-A1 | SUBSTITUTED TRIAZINE DERIVATIVES AND USE THEREOF AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-07-18 | — | — | WO | disclosed |
| EP-2611802-A1 | BICYCLIC AZA HETEROCYCLES, AND USE THEREOF | Bayer Intellectual Property GmbH (DE) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012028647-A1 | BICYCLIC AZA HETEROCYCLES, AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-08 | — | — | WO | disclosed |